DEC 01, 2015 7:29 PM PST

Microbiome Sequencing - From the Comfort of Home

WRITTEN BY: Kerry Evans
A San Francisco based startup called μBiome is partnering with the CDC to sequence your microbiome.

According to their website, “μBiome is the world’s first effort to map the human microbiome with citizen science.  Our sequencing provides information and tools for you to explore the populations of bacteria that live on and inside your body.  Based on research from the NIH Human Microbiome Project, we’ve perfected the technology to perform large-scale microbiome studies.  The knowledge we’ll gain may (one day) empower people to live healthier and accelerate our understanding of the world around us”.
?Biome will partner with the CDC to study the microbiome.

μBiome will collaborate with the CDC to develop a “microbiome disruption index” that could be used to track the effects of antibiotics and disease on gut microbes.  To do this, μBiome will sequence 10,000 stool samples that were obtained from hospital patients.  According to CDC epidemiologist Alison Halpin, “it’s possible for (microbiome sequencing) to become a standard tool.  We’re trying to anticipate that by understanding how you interpret that information”.  In the future, microbiome data could help physicians treat infections or predict disease outcomes - but that’s still a long way off.

μBiome also offers direct-to-consumer microbiome sequencing kits - think of it as 23andMe for bacteria.  There are currently three at-home kits to choose from:
  1. Gut Kit - this kit costs $89 and, according to their website, it’s “the best starter kit for curious beginners”.
  2. Gut Time Lapse Kit - this one costs $199.  It samples three time points - before, during, and after a lifestyle change.
  3. Five Site Kit - this one retails for $399 (ideal for the high-rolling citizen scientist).  It samples the gut, mouth, nose, genitals, and skin.
Once your samples are sequenced, you can access a report on the company’s website.  It contains information about each bacterial species and lets you compare results with other customers.  

One thing you won’t get is counseling or advice based on your results - the FAQ page is careful to note this.  It is for “personal research” and is not meant to be a diagnostic tool.  At this point, μBiome might just be a novelty for science-savvy consumers, but could certainly generate useful data for the future.  

Sources: μBiome, Wired
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
JAN 19, 2020
Genetics & Genomics
JAN 19, 2020
Engineering Mosquitoes to Stop Dengue Virus Transmission
The dengue virus is transmitted by mosquitoes. It is found in over one hundred countries and threatens three billion people with a serious illness....
FEB 05, 2020
Clinical & Molecular DX
FEB 05, 2020
A new CRISPR-based test for coronavirus infections
A surge in infections has caused panic surrounding the coronavirus (2019-nCoV) outbreak to reach a fever pitch. Despite being only moderately infective, 20...
FEB 14, 2020
FEB 14, 2020
CDC Director Expects Coronavirus to Find a "Foothold"
The novel coronavirus that emerged in Wuhan, Hubei Province, China has now infected over 64,000 people....
MAR 02, 2020
Drug Discovery & Development
MAR 02, 2020
DIY Fecal Transplants Improve Symptoms in 82% of People
Fecal transplants (FMT), the process of putting a healthy person’s fecal matter into another person’s colon, has been approved as a procedure t...
MAR 06, 2020
MAR 06, 2020
CDC Suggests Older Americans Should Stay Home As Much As Possible
The number of Americans who are infected with SARS-CoV-2 is increasing, and as more people are tested, that number is only going to rise....
MAR 08, 2020
Cell & Molecular Biology
MAR 08, 2020
How a Decoy Strategy Helps Cells Evade the Effects of Pathogens
Scientists have identified a strategy used by cells to shield them from the toxins that can be released by dangerous bacterial pathogens....
Loading Comments...